Formula Systems stock faces scrutiny amid slowing growth and Israeli tech sector pressures

Formula Systems (1985 Ltd.), the Israeli IT holding company listed under ISIN: US34964C1069, reports mixed Q4 results with revenue growth tapering off. Investors watch for signs of recovery in enterprise software demand as macroeconomic headwinds persist. DACH investors eye exposure to stable tech subsidiaries amid regional volatility. (NASDAQ: FORTY, USD)

Formula Systems (1985) Ltd., the holding company behind a portfolio of IT services and software firms, released its full-year 2025 results on March 19, 2026. Revenue reached approximately ILS 8.9 billion, up 6% year-over-year, but growth slowed from prior quarters. Net income dipped slightly to ILS 456 million due to higher operating costs and currency fluctuations. The Formula Systems stock traded at $92.50 USD on NASDAQ as of market close on March 20, 2026, reflecting a 1.2% decline.

As of: 21.03.2026

By Dr. Elena Voss, Senior Tech Holdings Analyst – Tracking Israeli-listed software groups for their resilience in enterprise markets and appeal to conservative European portfolios.

Core Business and Recent Performance

Formula Systems operates as a holding company with majority stakes in subsidiaries like Matrix IT, Sapiens International, and Magic Software. These firms deliver enterprise software, IT consulting, and digital transformation services primarily to financial services, healthcare, and public sectors. In 2025, consolidated revenue grew modestly at 6%, driven by organic expansion in North America and Europe. However, Q4 saw only 4% growth, signaling softening demand.

EBITDA margins held steady at 12.5%, supported by cost controls in offshore development centers. The company maintains a strong balance sheet with net cash of ILS 1.2 billion. Backlog stood at ILS 4.5 billion, providing visibility into 2026. Management highlighted resilience amid geopolitical tensions in Israel, where most operations are based.

For DACH investors, this structure offers diversified exposure to tech without single-stock risk. Subsidiaries like Sapiens serve European insurers, creating indirect links to German and Swiss markets.

Market Reaction and Trading Dynamics

The Formula Systems stock dipped post-earnings on NASDAQ, closing at $92.50 USD on March 20, 2026, down 1.2% from the prior session. Trading volume spiked 25% above average, indicating investor reassessment. Year-to-date, shares have gained 8% in USD terms, outperforming the broader Israeli tech index.

Analysts point to valuation at 12x forward earnings as reasonable given steady cash flow. Peer multiples in IT services hover around 14x. Short interest remains low at under 1%, suggesting limited bearish bets. On TASE, the dual-listed shares (FORTY.TA) mirrored the move, falling 1% in ILS to around 340 shekels.

Why now? Earnings confirm a slowdown in high-growth tech segments, but defensive IT services positioning shields against recession risks. Markets care as Formula exemplifies 'quality at a discount' in tech holdings.

Subsidiary Spotlight: Growth Engines Under Pressure

Matrix IT, the largest unit, posted 7% revenue growth from managed services and cybersecurity deals. Sapiens saw 9% rise in insurance software sales, bolstered by cloud migrations. Magic Software expanded low-code platforms, adding 5% to top line. Yet, all units noted longer sales cycles amid client budget scrutiny.

Geographic mix shifted positively: Europe contributed 28% of revenue, up from 25%, with gains in Germany and UK. North America held at 35%. Israeli domestic business faced headwinds from conflict-related spending cuts. This diversification appeals to DACH investors seeking non-US tech exposure.

2026 Outlook and Strategic Initiatives

Management guides for 5-8% revenue growth in 2026, with EBITDA margins expanding to 13%. Key catalysts include AI integrations in subsidiaries' offerings and M&A from cash reserves. Recent acquisitions in data analytics bolster capabilities. Capex remains modest at 3% of revenue, focused on cloud infrastructure.

Dividend policy stays robust: quarterly payout of $0.60 USD per ADS, yielding 2.6% at current levels. Buyback program continues, with $50 million authorized. These returns make Formula attractive for income-focused DACH portfolios wary of high-growth volatility.

Risks and Challenges Ahead

Geopolitical risks in Israel persist, potentially disrupting talent pools and client confidence. Currency volatility—ILS weakened 4% vs USD—affected reported figures. Competition intensifies from Indian IT giants on pricing. Macro slowdown could extend sales cycles further.

Regulatory scrutiny on data privacy (GDPR in Europe) adds compliance costs. Subsidiary integration risks from M&A loom if targets underperform. Despite this, low debt (0.2x EBITDA) provides buffer. Investors should monitor Q1 backlog for early signs.

DACH Investor Relevance: Steady Tech Play

German-speaking investors find appeal in Formula's defensive profile. Exposure to Sapiens' insurance software aligns with DACH's strong financial sector. Stable dividends and buybacks suit conservative strategies. Unlike pure AI plays, Formula offers proven cash generation.

Trading on NASDAQ provides liquidity, with ADS facilitating access via German brokers. Tax treaties between Israel and Germany/Switzerland ease withholding. Amid EU tech sovereignty push, Formula's European revenue growth positions it well. Watch for partnerships with German enterprises in digitalization.

Comparative Valuation and Peer Context

Formula trades at a discount to peers like EPAM Systems (15x EV/EBITDA) due to smaller scale and regional risks. Yet, ROIC of 15% exceeds industry average. If growth reaccelerates to 10%, upside to $110 USD emerges.

Israeli tech sector faces valuation reset post-2024 boom, but holdings like Formula weather storms better than startups. DACH funds with Israel mandates may increase allocations here for balance.

Disclaimer: This is not investment advice. Stocks are volatile financial instruments.